Search details
1.
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
Cell
; 177(7): 1701-1713.e16, 2019 06 13.
Article
in English
| MEDLINE | ID: mdl-31155232
2.
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Cell
; 175(7): 1731-1743.e13, 2018 12 13.
Article
in English
| MEDLINE | ID: mdl-30503213
3.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Cell Rep Med
; 3(10): 100783, 2022 10 18.
Article
in English
| MEDLINE | ID: mdl-36260981
4.
Targeting natural killer cells in solid tumors.
Cell Mol Immunol
; 16(5): 415-422, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30911118
5.
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer.
Clin Cancer Res
; 23(17): 5267-5280, 2017 Sep 01.
Article
in English
| MEDLINE | ID: mdl-28600477
6.
Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors.
J Proteomics
; 78: 231-44, 2013 Jan 14.
Article
in English
| MEDLINE | ID: mdl-23017497
Results
1 -
6
de 6
1
Next >
>>